Ewers SB - Search Results

1

Prognostic significance of flow cytometric DNA analysis and estrogen receptor content in breast carcinomas--a 10 year survival study.

Ewers SB, Attewell R, Baldetorp B, Borg A, Fernö M, Långström E, Killander D. Ewers SB, et al. Breast Cancer Res Treat. 1992;24(2):115-26. doi: 10.1007/BF01961244. Breast Cancer Res Treat. 1992. PMID: 8443399

2

Flow cytometry DNA analysis and prediction of loco-regional recurrences after mastectomy in breast cancer.

Ewers SB, Attewell R, Baldetorp B, Borg A, Fernö M, Långström E, Rydén S, Killander D. Ewers SB, et al. Acta Oncol. 1992;31(7):733-40. doi: 10.3109/02841869209083862. Acta Oncol. 1992. PMID: 1476753 Clinical Trial.

3

Prognostic potential of flow cytometric S-phase and ploidy prospectively determined in primary breast carcinomas.

Ewers SB, Attewell R, Baldetorp B, Borg A, Långström E, Killander D. Ewers SB, et al. Breast Cancer Res Treat. 1992 Jan;20(2):93-108. doi: 10.1007/BF01834639. Breast Cancer Res Treat. 1992. PMID: 1554892

4

One or multiple samplings for flow cytometric DNA analyses in breast cancer-prognostic implications?

Fernö M, Baldetorp B, Ewers SB, Idvall I, Olsson H, Sigurdsson H, Killander D. Fernö M, et al. Among authors: ewers sb. Cytometry. 1992;13(3):241-9. doi: 10.1002/cyto.990130305. Cytometry. 1992. PMID: 1576890 Free article.

5

Proliferation and DNA ploidy in malignant breast tumors in relation to early oral contraceptive use and early abortions.

Olsson H, Ranstam J, Baldetorp B, Ewers SB, Fernö M, Killander D, Sigurdsson H. Olsson H, et al. Among authors: ewers sb. Cancer. 1991 Mar 1;67(5):1285-90. doi: 10.1002/1097-0142(19910301)67:5<1285::aid-cncr2820670502>3.0.co;2-q. Cancer. 1991. PMID: 1991290

6

Flow cytometry DNA ploidy and number of cell populations in the primary breast cancer and their correlation to the prognosis.

Ewers SB, Baldetorp B, Killander D, Långström E. Ewers SB, et al. Acta Oncol. 1989;28(6):913-8. doi: 10.3109/02841868909092331. Acta Oncol. 1989. PMID: 2611041

7

Recurrence-free survival in breast cancer improved by adjuvant tamoxifen--especially for progesterone receptor positive tumors with a high proliferation.

Fernö M, Baldetorp B, Bendahl PO, Borg A, Ewers SB, Olsson H, Rydén S, Sigurdsson H, Killander D. Fernö M, et al. Among authors: ewers sb. Breast Cancer Res Treat. 1995;36(1):23-34. doi: 10.1007/BF00690181. Breast Cancer Res Treat. 1995. PMID: 7579503 Clinical Trial.

8

Prognostic factors in head and neck cancer: histologic grading, DNA ploidy, and nodal status.

Zätterström UK, Wennerberg J, Ewers SB, Willén R, Attewell R. Zätterström UK, et al. Among authors: ewers sb. Head Neck. 1991 Nov-Dec;13(6):477-87. doi: 10.1002/hed.2880130603. Head Neck. 1991. PMID: 1791143

9

Flow-cytometric DNA analysis in primary breast carcinomas and clinicopathological correlations.

Ewers SB, Långström E, Baldetorp B, Killander D. Ewers SB, et al. Cytometry. 1984 Jul;5(4):408-19. doi: 10.1002/cyto.990050419. Cytometry. 1984. PMID: 6468179 Free article.

10

A biological marker, strongly associated with early oral contraceptive use, for the selection of a high risk group for premenopausal breast cancer.

Olsson H, Borg A, Ewers SB, Fernö M, Möller T, Ranstam J. Olsson H, et al. Among authors: ewers sb. Med Oncol Tumor Pharmacother. 1986;3(2):77-81. doi: 10.1007/BF02934557. Med Oncol Tumor Pharmacother. 1986. PMID: 3747639

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

34 results

Search Page

Filters